Mesalazine prophylaxis could be used to prevent colorectal cancer

摘要

Evidence is building that prophylaxis with mesalazine (5-aminosalicylic acid, 5-ASA) is effective in preventing colorectal cancer in patients with inflammatory bowel disease (IBD), according to a leading gastroenterologist.